Resection and Immunotherapy for Recurrent Grade III Glioma

Table 2

AA, AOD, and AOA characteristics.

	AA	AOD	AOA
Median medical history prior to immunotherapy (m)	39.5	118.4	72
Median OS (m)	20.5	18.8	13.3
Median PFS (m)	4.6	3.4	7.8
Median interval PFS/death (m)	15.9	15.4	5.5
6 months PFS (%)	37.5	33.3	66
12 months PFS (%)	37.5	25	50
24 months PFS (%)	30	25	25
6 months OS (%)	94.2	92.3	75
12 months OS (%)	76.5	77	62.5
24 months OS (%)	41.2	39.6	46.9

OS: Overall survival, PFS: progression free survival, AA: anaplastic astrocytoma, AOD: anaplastic oligodendroglioma, AOA: anaplastic oligoastrocytoma.